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SI Materials and Methods
Cloning, Expression, and Purification.All constructs and specifically
the major Bag6 isoform 2 were derived from human cDNA. For
crystallization, both Bag6(1,000–1,054) and TRC35(23–305)
were inserted into the multiple cloning site of the pACYCDuet
plasmid (Novagen) with an N-terminal hexahistidine tag on Bag6
(1000–1054). The plasmid was transformed into E. coli NiCo21
(DE3) (New England Biolabs). The plate was scraped to in-
oculate 12 2L baffled flasks containing 2×YT medium then
grown by shaking at 37 °C in a shaking incubator (Multitron
Standard; Infors HT) at 250 rpm. Cell growth was monitored
to an OD600 = 0.6 then protein expression was induced for 3 h
by the addition of 500 μM isopropyl-β-D-thiogalactopyranoside
(IPTG) (Affymetrix). Cells were harvested by centrifugation in a
TLA 8.1 rotor at 4,000 ×g for 20 min. The pellet was resus-
pended in 50 mM Mops (pH 7.2), 300 mM K·glutamate, 5 mM
MgOAc, 20 mM imidazole, 5 mM β-mercaptoethanol (1 g cell/
10 mL lysis buffer) and supplemented with 0.1 mM PMSF and
1 mM benzamidine. Cells were lysed using an M-110L micro-
fluidizer (Microfluidics) by two passes at ∼17,500 psi. The lysate
was clarified by centrifugation at 235,000 ×g in a Beckman
Ti45 rotor for 30 min at 4 °C. The clarified lysate was incubated
for 1 h with 3 mL of a 50% (vol/vol) slurry of nickel-
nitrilotriacetic acid (Ni-NTA) agarose (Qiagen) by rocking.
The mix was poured into a gravity column then washed with
100 mL lysis buffer. The protein was eluted with 12 mL elution
buffer (20 mM Mops (pH 7.2), 150 mM K·glutamate, 300 mM
Imidazole, 5 mM β-mercaptoethanol). The eluent was mixed
with ∼0.5 mg of TEV protease in snakeskin dialysis tubing with
10 kDa molecular weight cutoff (Thermo Fisher Scientific) and
dialyzed overnight at room temperature in (20 mM Mops (pH
7.2), 100 mM K·glutamate, and 10 mM β-mercaptoethanol).
Precipitate was removed by centrifugation with Beckman
SX4750A rotor at 3,000 ×g for 5 min at 4 °C and filtered with a
0.22 μm syringe filter. The sample was concentrated and loaded
onto a 5 mL UnoQ ion-exchange column (Bio-Rad) then eluted
with a 60 mL 20 mM Mops (pH 7.2), 50–500 mM K·glutamate
gradient, 5 mM β-mercaptoethanol. The fractions containing the
protein (∼5–23 mL) were dialyzed in snakeskin dialysis bag in
20 mM Mops (pH 7.2), 50 mM K·glutamate, 5 mM β-mercap-
toethanol for 2 h at 4 °C. The sample was concentrated to 2 mL,
filtered with a 0.22-μm syringe filter, then further purified
by size-exclusion chromatography over a 120 mL Superdex
75 column (GE Healthcare) (20 mM Mops (pH 7.2), 50 mM
K·glutamate, 5 mM β-mercaptoethanol). The fractions contain-
ing the heterodimer (61 mL–72 mL) and monomeric Bag6 (77–
82 mL) were pooled and concentrated to ∼10 mg/mL using
centrifugal filter units with 10 kDa molecular weight cutoff
(Merck Millipore).
The plasmid containing human KPNA2 was obtained from
Addgene (#26677). A truncated KPNA2 (58–529) was subcl-
oned into pMAL-C2 vector (New England Biolabs) and trans-
formed into E. coli NiCo21(DE3). The cells were grown in 2×YT
medium and induced at 37 °C until OD600 = 0.1 and then were
cooled on ice for 1 h. Expression was induced with 500 μM IPTG
for 18 h at 16 °C in a shaking incubator at 200 rpm. The cells
were harvested as above and resuspended in 50 mM Mops (pH
7.2), 300 mM K·glutamate, 5 mM β-mercaptoethanol, supple-
mented with cOmplete EDTA-free protease inhibitor mixture
(Roche) and lysed using the M-110L microfluidizer by two
passes at ∼17,500 psi. The lysate was clarified by centrifugation
at 235,000 ×g in a Beckman Ti45 rotor for 30 min at 4 °C. The
lysate was incubated for 1 h with 3 mL of a 50% (vol/vol) slurry
of amylose resin (New England Biolabs) by rocking. The mix was
poured into a gravity column then washed with 100 mL lysis
buffer. The protein was eluted with 12 mL elution buffer (20 mM
Mops (pH 7.2), 150 mM K·glutamate, 10 mM maltose, 5 mM
β-mercaptoethanol). The sample was placed in snakeskin dialysis
bag (10 kDa cutoff, Thermo Fisher) and dialyzed overnight at
4 °C in 20 mMMops (pH 7.2), 50–800 mM K·glutamate gradient,
5 mM β-mercaptoethanol. The fractions containing the protein
(∼36–70 mL) were pooled and dialyzed in snakeskin dialysis
bag in 20 mM Mops (pH 7.2), 50 mM K·glutamate, 5 mM
β-mercaptoethanol for 2 h at 4 °C. The sample was concentrated
to 2 mL, filtered with a 0.22-μm syringe filter, and purified by
size-exclusion chromatography over a 120-mL Superdex
200 column (GE Healthcare) (20 mM Mops (pH 7.2), 50 mM
K·glutamate, 5 mM β-mercaptoethanol). Fractions containing
the sample (60 mL–90 mL) were pooled and concentrated with
centrifugal filtration units with a 50-kDa cutoff.
For expression and purification of GST·TRC35, full-length
TRC35 was subcloned into pGEX6P-1 (GE Healthcare) and
transformed into NiCo21(DE3). The cells were grown at 37 °C
until OD600 = 0.1, chilled on ice for 1 h, then induced with
500 μM IPTG at 16 °C for 18 h in a shaking incubator at
200 rpm. Cells were lysed using 10 mL lysis buffer [50 mM Hepes
(pH 7.2), 400 mM KCl, 5 mM mercaptoethanol] per g cell pellet
and were incubated with 3 mL 50% (vol/vol) slurry of glutathi-
one resin (GE Healthcare) for 2 h at 4 °C by rocking. The resin
was washed with 100 mL lysis buffer, and the protein was eluted
with 12 mL of freshly prepared 20 mM Hepes (pH 7.2), 150 mM
KCl, 33 mM glutathione, 5 mM β-mercaptoethanol. The sample
was placed in snakeskin dialysis bag (10 kDa cutoff) (Thermo
Fisher) and dialyzed overnight at 4 °C in 20 mM Hepes (pH 7.2),
100 mM K·glutamate, 5 mM β-mercaptoethanol, before concen-
tration with centrifugal filter unit (50-kDa cutoff) (Millipore).
Crystallization. Crystallization screening was performed using
the sitting-drop vapor-diffusion method with the commercially
available PEG Ion screen (Hampton Research) and MRC 2Well
Crystallization plate (Hampton Research). Initial screening was
performed by a Mosquito robot (TTP Labtech) with 100 nL
protein:100-nL drops of well solution and 50-uL wells. No re-
finement was necessary. Crystals grew to full size after 5 d as
rectangular prisms in 20% PEG-3350 (Wt/vol), 0.2 M DL-malic
acid (pH 7.0). For cryoprotection, crystals were transferred into
100 uL of well solution with 20% (vol/vol) glycerol for 15 s and
then were frozen in liquid nitrogen. Rubidium derivatives were
generated by transferring crystals into 40 μL of well solution plus
350 mM rubidium iodide for 2–10 s before cryopreservation with
glycerol.
Data Collection, Structure Solution, and Refinement. X-ray diffrac-
tion data were collected on Beam line BL12-2 at the Stanford
Synchrotron Radiation Laboratory (SSRL). A complete native
dataset was collected from a single crystal to 1.8 Å resolution, and
a single rubidium derivative crystal dataset was collected from a
single crystal to 2.0 Å with a Dectris Pilatus 6M detector. Data
were integrated, scaled, and merged using XDS (44) and SCA-
LA (45, 46). Phases were determined by molecular replace-
ment single-wavelength anomalous dispersion (MRSAD) using
SHARP (47) and PHASER-MR (48) on PHENIX (49). The
initial structure was built by PHASER as implemented by
PHENIX (49). The model was further built and refined against
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the native dataset over several rounds using COOT (50) and
PHENIX (49). Statistics are provided in Table S1.
Phylogenetic Tree of GET/TRC Components. The phylogenetic tree
was modified from the maximum-likelihood phylogenetic tree of
eukaryotes by Eme et al. (51) The MEME suite (43) was used to
determine the presence or absence of the GET/TRC components
in the genomes presented in the tree. TheMEMEmotif discovery
tool was used to make motifs for Ubl4A, Get5, Get4/TRC35,
Sgt2, SGTA, and Bag6. The motifs were then used to search the
genomes using the motif-scanning tool MAST (52). Identified
proteins were confirmed using BLAST (53) and the corre-
sponding reference ID is provided on Table S2.
Yeast Two-Hybrid. The PJ69-4α strain was obtained from the
Yeast Resource Center at the University of Washington.
Bag6 isoform 2 residues 951–1,126 were cloned into the pGAD-
C1 vector, and TRC35 was cloned into pGBDU-C1 vector. Al-
anine mutations were made using Q5 site-directed mutagenesis
(New England Biolabs). pGAD-C1–TRC35 (WT or mutant) and
pGBDU-C1–Bag6 (WT or mutant) were cotransformed into
PJ69-4α using previously described methods (54) and then were
plated onto SC-Ura-Leu plates and incubated at 30 °C. Single
colonies from the transformants were cultured in 5 mL SC-Ura-
Leu liquid medium and grown overnight in a shaking incubator
(Multitron Standard Infors HT) at 200 rpm at 30 °C. Then 2 ×
107 cells were transferred into a total of 5 mL SC-Ura-Leu
medium and grown in a shaking incubator at 30 °C at 200 rpm
for 6 h. Cells were harvested by centrifugation with a Beckman
SX4750A rotor at 3,000 × g at 25 °C. The cells were washed twice
by resuspension in 5 mL of sterile water followed by centrifu-
gation at 3,000 × g at 25 °C. After the second wash, cells were
resuspended in 1 mL sterile water. Concentration was measured,
and 1 × 107 cells were resuspended in a total volume of 40 μL of
sterile water. Four microliters of this resuspended sample were
spot-plated onto a SC-Ura-Leu-Ade plate and incubated for 72 h
at 30 °C.
Yeast Two-Hybrid Expression Controls. Cells were grown overnight
in SC-Ura-Leu medium. Then 2.5 × 107 cells were transferred to
a total volume of 5 mL medium and grown for ∼6–8 h until
OD600 = 2.0. Cells were harvested by centrifugation at 4,000 × g
for 5 min at 4 °C. Cells were resuspended in 2 mL 10 mM TE
buffer [Tris·HCl (pH 8.0), 0.1 mM EDTA]. Cells were centri-
fuged in a microcentrifuge at 13,500 × g at 4 °C for 2 min. Ap-
proximately 37.5 μL of glass beads (415–600 μm) for each OD
unit were added to the sample. The same volume of 1× SDS/
PAGE loading buffer was added. The cells were vortexed and
immediately plunged into a boiling water bath. After boiling for
3 min, tubes were immersed in an ice bucket. The tubes were
placed into FastPrep (MP Biomedicals) homogenizer at 6 m/s for
45 s. Cells were boiled for 3 min and centrifuged in a micro-
centrifuge for 2 min at 13,500 × g at room temperature. Super-
natant was transferred to a clean microfuge tube and loaded
onto 5–20% gradient gel (Bio-Rad). The protein was transferred
onto PVDF membrane. Membrane was blocked with Odyssey
TBS blocking buffer (LI-COR) for 1 h. The membrane was in-
cubated with a primary Ab against the Gal4 DNA-binding do-
main (Santa Cruz) for TRC35 detection or Gal4 transactivating
domain (Santa Cruz) for Bag6 detection. After washing three
times with TBST [20 mM Tris·HCl (pH 7.5), 150 mM NaCl,
0.2% Tween-20] for 10 min , membrane was incubated with anti-
mouse secondary Ab (IRDye 680RD or 800CW; LI-COR) for
1 h at room temperature. Membrane was washed three times
with TBST for 10 min each. Proteins were detected using an
Odyssey Imaging System (LI-COR).
IP from 293T Cells.On day 0, 5 × 105 Bag6−/− cells were seeded in
plates. On day 1, TRC35 with a C-terminal FLAG tag
(TRC35·FLAG), Bag6 with a C-terminal GFP tag (WT or mu-
tant Bag6·GFP), and HA·ubiquitin were cotransfected. On day 3,
cells were collected and washed with 1 mL of ice-cold PBS. The
cells were lysed with Nonidet P-40 lysis buffer containing 1 mM
N-ethylmaleimide to inhibit the ubiquitin–proteasome system.
The detergent soluble fraction was used for IP using GFP Ab.
After IP, the beads were divided into two fractions. Half was
analyzed directly with SDS/PAGE and immunoblotting with in-
dicated Abs to assess the interaction between TRC35 and
Bag6 and Bag6 mutants. The other half was used for denaturing
IP to detect TRC35 ubiquitylation. The beads were resuspended
in 150 μL denaturing buffer (1× PBS, 1% SDS, 5 mM DTT) and
heated at 95 °C for 10 min. Then 1.35 mL Nonidet P-40 lysis
buffer was added into the tube and incubated at 4 °C for 30 min.
The supernatant was used for IP with FLAG A-conjugated
M2 beads (Sigma-Aldrich). The eluate was analyzed with SDS/
PAGE and immunoblotting.
To assay TRC35 ubiquitylation after proteasome inhibition, 5 ×
105 WT 293T cells were seeded in plates on day 0. On day 1, cells
were transfected as above. Twenty-four hours post transfection,
proteasome inhibitor, MG132, was added to the concentration of
10 μM and incubated overnight. Cells were collected and ana-
lyzed with sequential IP and immunoblotting as above.
To investigate the effect of simultaneous RNF126 down-
regulation and proteasomal inhibition on TRC35 ubiquitylation,
5 × 105 Bag6 293T cells were seeded in plates on day 0. On day 1,
cells were transfected with RNF126 siRNA or control siRNA. On
day 2, cells were split in half into new plates. After ∼9 h, plasmids
encoding TRC35·FLAG (WT), Bag6·GFP (WT or mutant) and
HA·ubiquitin were transfected. On day 3, medium was replaced
with fresh medium containing either 10 μM MG132 or DMSO.
On day 4, cells were collected, and sequential IP was performed as
described above.
Localization Assay.On day 0, 1 × 105 Cos7 cells were seeded onto a
12-well plate with a poly-D-lysine–coated cover glass. After ∼8 h,
the cells were cotransfected with TRC35·FLAG and Bag6•GFP
(WT or mutant). Twenty hours after transfection, the cells were
washed with 1× PBS, fixed with 4% (vol/vol) paraformaldehyde
for 15 min, then washed with 1× PBS before permeabilization
with staining solution [1× PBS, 5% FBS (vol/vol), 0.1% (vol/vol)
Nonidet P-40]. Cells were then stained with staining solution
containing primary Ab and incubated at room temperature for
1 h. After washing the cells with 1× PBS, the cells were incubated
with staining solution with secondary Ab and then were washed
with 1× PBS. Cells were counterstained with a mounting medium
containing DAPI to illuminate the nucleus for visualization with
Axiovert 200M microscope (Zeiss). Confocal microscope anal-
yses were performed with a Zeiss LSM 780 system.
To assay the localization of each Bag6 mutant, three view fields
were evaluated with a 40× oil immersion objective. Approximately
100 cells were evaluated for each Bag6 variant, and cells were
counted as having Bag6 primarily in either the nucleus or the cytosol.
In Vitro Binding Assay with Purified Proteins. 1 nmol hexahistidine-
tagged Ubl4A–Bag6C131 (WT, 1025SL, or 1043SL) was incubated
with 1 nmol GST·TRC35 or 1 nmol MBP·KPNA2 in a 100-μL
total volume of binding buffer [20 mM Mops (pH 7.2), 100 mM
K·glutamate 20 mM imidazole, 5 mM β-mercaptoethanol] at room
temperature for 30 min. Then 30 μL 50% slurry of Ni-NTA beads
(Qiagen) equilibrated with binding buffer were added to the re-
action and incubated at room temperature for 30 min. The beads
were resuspended using a pipet every 10 min. The beads were
then washed twice with 100 μL of room-temperature binding
buffer. Samples bound to the resin were eluted with 25 μL of
elution buffer [20 mM Mops (pH 7.2), 100 mM K·glutamate,
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300 mM imidazole, 5 mM β-mercaptoethanol] and evaluated with
Coomassie-stained SDS/PAGE gel.
Exchange Assay. One nanomole of hexahistidine-tagged Ubl4A–
Bag6C131 (WT, 1024SL, or 1043SL) was incubated with 1 nmol
GST·TRC35 in 100 μL total volume of binding buffer [20 mM
Mops (pH 7.2), 100 mM K·glutamate, 20 mM imidazole, 5 mM
β-mercaptoethanol]. Thirty microliters of a 50% (vol/vol) slurry
of glutathione beads (GE Healthcare) equilibrated with binding
buffer were added to the reaction and incubated at room tem-
perature for 30 min. The beads were resuspended every 10 min.
The beads were washed twice with 100 μL of room-temperature
binding buffer [20 mM Mops (pH 7.2), 100 mM K·glutamate,
5 mM β-mercaptoethanol]; then 0.5, 1, or 2 nmol of MBP·KPNA
in 100 μL was added to the resin and incubated for 30 min at
room temperature. The beads were washed twice with 100 μL
binding buffer and then were eluted with 25 μL elution buffer
[20 mM Mops (pH 7.2), 100 mM K·glutamate, 33 mM glutathione,
5 mM β-mercaptoethanol]. The reverse experiment starting with
hexahistidine-tagged Ubl4A–Bag6C131 and MBP·KPNA2 was
carried out as above but using 30 μL of a 50% (vol/vol) slurry of
amylose beads (New England Biolabs) in 20 mM Mops (pH 7.2),
100 mMK·glutamate, and 5 mM β-mercaptoethanol and was eluted
with 25 μL of 20 mMMops (pH 7.2), 100 mM K·glutamate, 10 mM
maltose, and 5 mM β-mercaptoethanol.
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Fig. S1. Comparison of TRC35 and Get4 structures. (A) Representative structures of fungal Get4 homologs. 3LKU is from Saccharomyces cerevisiae (Sc) and
3LPZ is from Chaetomium thermophilum. (B) Aligned human TRC35 (color ramped) and ScGet4 (3LKU, gray) using Pymol (55) super for sequence-independent
structural alignment. (Left) Structures aligned to the six N-terminal helices. (Right) Structures aligned to the seven C-terminal helices. (C) Accessible surface
representation of TRC35 colored based on percent conservation as implemented in Chimera (56). Conservation based on a MAFFT (57) alignment of TRC35/
Get4 sequences from Homo sapiens, Xenopus laevis, Danio rerio, Drosophila melanogaster, Nematostella vectensis,Monosiga brevicollis, Schizosaccharomyces
pombe, and Saccharomyces cerevisiae. Bag6 is in ribbons representation in pink. (D) The Bag6-binding surface of TRC35 colored based on hydrophobicity (Kyle–
Doolittle scale) and percent conservation as implemented in Chimera (56).
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Fig. S2. Survey of factors involved in the TRC pathway in eukaryotes (Table S3). A condensed phylogenetic tree of representative eukaryotes was built based
on the maximum likelihood phylogenetic tree of eukaryotes by Eme et al. (51). The genome of each organism was searched for the presence of Get4/TRC35,
Get3/TRC40, and Bag6 using MEME suite motif discovery tool (MEME) (43) and motif-scanning tool (MAST) (58) in addition to NCBI protein BLAST (58). Proteins
are color coded and sequence elements are highlighted. Black circles indicate homologs that are missing residues demonstrated to be critical in fungal TA-
targeting studies. Pink asterisk indicates that although a clear Bag6 homology could not be identified in the genome of Caenorhabditis elegans, Bag6-like
proteins have been identified in genomes of other nematodes: Brugia malayi, Loa loa, Wuchereria bancrofti, and Toxocara canis.
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Fig. S3. Representative aligned sequences of eukaryotic TRC35/Get4. Species selected based on the eukaryotic phylogenetic tree by Eme et al. (51). Sequences
were aligned with MAFFT (57). α-Helices, based on the TRC35 structure, are highlighted in colors that correspond to the crystal structure on Fig. 1B and
numbered on top. Residues highlighted in red boxes were identified as critical to fungal Get4 binding Get3 (13). Residues highlighted in blue boxes are critical
to Get4/TRC35 regulating Get3/TRC40 (4, 13). The residues that comprise the fungal β-hairpin are highlighted in a black box. The arrow indicates the end of the
crystallization construct. Purple boxes highlight glutamate and aspartate residues in the C terminus of TRC35.
Mock et al. www.pnas.org/cgi/content/short/1702940114 6 of 11
Ve
ct
or
IB FLAG 
(TRC35•FLAG)
IB GFP 
(Bag6•GFP)
w
ild
 ty
pe
W
10
04
A
W
10
12
A
Y1
03
6A
W
10
04
A
/Y
10
36
A
W
10
12
A
/Y
10
36
A
5% INPUT IP GFP
Ve
ct
or
w
ild
 ty
pe
W
10
04
A
W
10
12
A
Y1
03
6A
W
10
04
A
/Y
10
36
A
W
10
12
A
/Y
10
36
A
140 30 15 14 20 22
39 57 61 59 37 25
MW
250
150
100
75
50
37
25
20
lanes1 2 3 74 5 6 8 9 10 1411 12 13
MW
250
150
100
75
50
37
25
20
*
*
*
345 133 45 31 51 72
152 155 165 186 189 152
*
*
*
Ba
g6
 (9
51
-1
12
6)
 
TR
C3
5
Bag6 (951-1126)
SC-Ura-Leu
SC-Ura-Leu
SC-Ura-Leu-Ade
WT W1004A V1008A W1012A
TRC35
I1016A L1032A Y1036A M1040A
Ba
g6
 (9
51
-1
12
6)
 
TRC35
WT V182A F188A M194A
F195A W241A F242A V257A
L258A C259A Y262A L266A
A
C
B
D
E
TR
C3
5
Bag6 (951-1126)
SC-Ura-Leu-Ade
WT V1008AW1004A W1012A
I1016A L1032A Y1036A M1040A
IB FLAG 
(TRC35•FLAG)
IB GFP 
(Bag6•GFP)
WT V182A F188A M194A
F195A W241A F242A V257A
L258A C259A Y262A L266A
PJ
69
4α
M
ar
ke
r
PJ
-6
PJ
-3
5
PJ
6+
35
PJ
6(
10
04
A
/1
03
6A
)
PJ
6(
10
12
A
/1
03
6A
)
PJ
35
(Y
26
2A
)
37 IB Gal4-AD (Bag6)
Ponceau
IB Gal4-BD (TRC35)50
PJ
69
4α
M
ar
ke
r
PJ
-6
PJ
-3
5
PJ
6+
35
PJ
6(
10
04
A
/1
03
6A
)
PJ
6(
10
12
A
/1
03
6A
)
PJ
35
(Y
26
2A
)
Fig. S4. Validation of the Bag6–TRC35 interface. (A) Yeast two-hybrid assay to validate the interface identified in the crystal structure. WT or mutant full-
length TRC35 conjugated to the DNA binding domain was expressed with WT Bag6(951–1126) conjugated to the transcription activating domain. Trans-
formation was confirmed by ability to grow on SC-Ura-Leu plates. Interaction was determined by ability to grow on SC-Ura-Leu-Ade medium. (B) Western blot
analysis of yeast whole-cell lysate for proper expression of prey and bait proteins. Whole-cell lysates of PJ694α (without plasmid), PJ6 (PJ694α transformed with
wtBag6), PJ-35 (PJ694α transformed with wtTRC35), PJ6+35 (PJ694α transformed with WT Bag6 and wtTRC35), PJ6(1004A/1036A) (PJ694α transformed with
wtTRC35 and Bag6(W1004A/Y1036A), PJ6(1012A/1036A) (PJ694α transformed with wtTRC35 and Bag6(W1012A/Y1036A), and PJ35(Y262A) (PJ694α trans-
formed with wtBag6 and TRC35(Y262A) were analyzed by immunoblotting with indicated Abs. (C) WT full-length TRC35 conjugated to the DNA binding
domain was expressed with WT or mutant Bag6(951–1126) conjugated to the transcription activating domain. (D and E) WT or mutant Bag6·GFP was coex-
pressed in Bag6−/− 293T cells with TRC35·FLAG and immunoprecipitated using anti-GFP Ab. Amount of TRC35 retrieved by Bag6 was assessed by blotting with
anti-FLAG Ab. The positions of the higher molecular weight TRC35·FLAG are indicated by asterisks.
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Fig. S5. Ubiquitylation of TRC35 in cells expressing Bag6 mutants. (A) IP of TRC35 in Bag6−/− 293T cells cotransfected with plasmids encoding TRC35·FLAG
(WT), Bag6·GFP (WT or mutants), and HA·ubiquitin. Anti-GFP Ab was used for the first IP. Anti-FLAG Ab was used for the second IP in denaturing conditions.
TRC35 ubiquitylation was assessed by immunoblotting with anti-HA Ab. The exposure times were adjusted to improve visibility of the reactive bands. (B) IP was
carried out as in A in Bag6−/− 293T cells cotransfected with plasmids encoding TRC35·FLAG (WT) and Bag6·GFP (WT or mutants). TRC35 ubiquitylation was
assessed by immunoblotting with anti-FLAG Ab. The exposure times were adjusted to improve visibility of the reactive bands. (C) The cell extract used for IP
was immunoblotted for Bag6, TRC35, and HA·ubiquitin with Bag6 Ab, FLAG Ab, and HA Ab, respectively.
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Fig. S6. The effect of RNF126 on TRC35 stabilization. Immunoblot analysis of the effect of RNF126 on TRC35 levels in wt293T cells cotransfected with plasmids
encoding TRC35·FLAG (WT), Bag6·GFP (WT or mutants), and HA·ubiquitin. A combination of three siRNAs against RNF126 was used. Bag6 and TRC35 levels
were assessed by immunoblotting with anti-GFP and anti-FLAG Abs.
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Fig. S7. The second basic cluster of Bag6 is necessary and sufficient for binding karyopherin α 2. (A) The putative bipartite nuclear localization sequence of
Bag6. The serine and leucine mutations introduced in this study are highlighted. (B) Recombinantly purified Bag6C131–6xHis·Ubl4A (500 pmol) was incubated with
twofold excess GST·TRC35 or MBP·KPNA2 for 20 min at room temperature. Ni-NTA beads were used to capture purified Bag6C131–6xHis·Ubl4A and bound factors.
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Table S1. Data collection and refinement statistics
Statistics Native Rubidium
Data collection
Protein Bag6–TRC35 Bag6–TRC35
Synchrotron SSRL SSRL
Beamline 12-2 12-2
Space group P 21 21 21 P21 21 21
Cell dimensions
a, b, c, Å 41.7, 84.6, 102.6 42.0, 84.3, 102.5
α, β, γ, ° 90.0 90.0, 90.0 90.0, 90.0, 90.0
Wavelength 0.9200 0.8154
Resolution, Å 39.1–1.80 (1.92–1.80) 50.0–1.99 (2.11–1.99)
Rmeas*, % 9.3 (64.3) 16.9 (118.8)
I/σ(I) 16.9 (3.8) 14.9 (2.1)
CC1/2, % 99.9 (95) 99.9 (88.0)
Completeness*, % 98.7 (92.7) 99.2 (95.6)
No. of observations 384,047 (60,190) 655,714 (96,962)
No. of unique reflections* 40,776 (6,194) 47,793 (7,417)
Redundancy* 9.4 (9.7) 13.7 (13.1)
Refinement
Resolution, Å 39.1–1.80
No. of reflections 34,334
No. of reflections test set 1,998
Rwork/Rfree 15.8/20.0
No. atoms (nonhydrogen) 2,738
Protein 2,574
Water 152
Ligand/Ions 12
B-factors
Protein 31.7
Water 39.0
RMSD
Bond lengths, Å 0.010
Bond angles, ° 1.16
Ramachandran plot
Favored, % 98
Additionally allowed, % 2.0
Outliers, % 0.0
*Highest-resolution shell is shown in parentheses.
Table S2. Gene IDs used in Fig. S2
Species TRC35 TRC40 Bag6
Homo sapiens NP_057033.2 NP_004308.2 NP_004630.3
Gallus gallus XP_015149638.1 XP_015158190.1
Branchiostoma floridae XP_002607071.1 XP_002605952.1 XP_002594881.1
Drosophila melanogaster NP_649464.1 NP_610296.2 NP_648132.2
Caenorhabditis elegans NP_498034.1 NP_498965.1
Schistosoma mansoni XP_018645653.1 XP_018648676.1 XP_018648249.1
Nematostella vectensis XP_001640454.1 XP_001638254.1 XP_001635433.1
Amphimedon queenslandica XP_011404841.1 XP_003385895.1
Monosiga brevicollis XP_001750773.1 XP_001743630.1
Capsaspora orwazaki XP_004342754.1 XP_004363354.1
Fonticula alba KCV72828.1 XP_009492379.1
Saccharomyces cerevisiae NP_014807.3 NP_010183.1
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Table S3. Statistics used for data quantification in Fig. 4
Bag6 variant Cytosolic Bag6, no. of cells Nuclear Bag6, no. of cells Total no. of cells
wtBag6 77 7 84
Bag6(W1004A) 50 30 80
Bag6(W1012A) 35 65 100
Bag6(Y1036A) 32 56 88
Bag6(W1004A/1036A) 18 113 131
Bag6(W1012A/1036A) 15 137 152
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